Data Standards in Diabetic Kidney Disease
Overview
In coordination with the Clinical Data Interchange Standards Consortium (CDISC), Coalition for Accelerating Standards and Therapies (CFAST), FDA, and TransCelerate BioPharma, Inc., KHI assembled a working group that helped define appropriate standards in the therapeutic area of diabetic kidney disease. KHI's specific role was providing clinical and medical expertise.